The antifibrotic effect and mechanism of a novel tyrosine kinase inhibitor, ZSP1603, in preclinical models of pulmonary fibrosis.

Zongwen Liu, Min Zhao, Xinliang Su, Ye Tao, Yuan Zhuang, Yi Zhang, Zhongzhi Zhang, Yang Jl, Ling‐Jyh Chen, C.-f. Long, Yanli Yao, X.-x. ChenPubMed 2020 · DOI

Abstract

ZSP1603 is an effective anti-fibrotic compound with clear mechanisms.
BibTeX
@inproceedings{liu2020antifibrotic,
  author = {Zongwen Liu and Min Zhao and Xinliang Su and Ye Tao and Yuan Zhuang and Yi Zhang and Zhongzhi Zhang and Yang Jl and Ling‐Jyh Chen and C.-F. Long and Yanli Yao and X.-X. Chen},
  title = {{The antifibrotic effect and mechanism of a novel tyrosine kinase inhibitor, ZSP1603, in preclinical models of pulmonary fibrosis.}},
  booktitle = {PubMed},
  year = {2020},
  doi = {10.26355/eurrev\_202002\_20207},
}

Loading related content...

Figure